|
End-of-day quote
Shanghai S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 14.39 CNY | +2.49% |
|
+1.34% | -4.51% |
| 15/10 | Huachuang Securities Starts Tasly Pharmaceutical Group at Add with 17.20 Yuan Price Target | MT |
| 15/10 | Tasly Pharmaceutical Wins Clinical Trial Approval for TDX105 Granules | MT |
| Market Cap | 2.15TCr 321.47Cr 286.56Cr 265.45Cr 241.36Cr 452.9Cr 30TCr 460.34Cr 3.18TCr 1.25TCr 16TCr 1.21TCr 1.18TCr 51TCr | P/E 2026 * |
16.1x | P/E 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2TCr 298.38Cr 265.98Cr 246.39Cr 224.02Cr 420.37Cr 28TCr 427.28Cr 2.96TCr 1.16TCr 15TCr 1.12TCr 1.1TCr 47TCr | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.69x |
| Free-Float |
47.11% | Yield 2026 * |
2.7% | Yield 2027 * | 3.27% |
| 1 day | +2.49% | ||
| 1 week | +1.34% | ||
| Current month | +2.79% | ||
| 1 month | +3.82% | ||
| 3 months | -6.44% | ||
| 6 months | +0.98% | ||
| Current year | -4.51% |
| 1 week | 13.92 |  | 14.44 |
| 1 month | 13.64 | | 14.44 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.24 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 10/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 08/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.49% | +1.34% | -9.50% | +2.57% | 313.47Cr | |
| -1.33% | +5.18% | +54.50% | +104.26% | 1,12000Cr | |
| -0.69% | -2.93% | +31.35% | +66.17% | 62TCr | |
| -0.96% | +2.25% | +23.13% | +89.36% | 50TCr | |
| +0.24% | +6.23% | +33.98% | +52.38% | 37TCr | |
| -1.59% | -1.35% | +69.39% | +40.83% | 36TCr | |
| -0.40% | +4.28% | +19.17% | +42.51% | 29TCr | |
| -0.37% | +3.35% | -1.26% | +16.85% | 26TCr | |
| -1.75% | +2.43% | +42.21% | +49.85% | 23TCr | |
| -2.00% | +1.26% | +24.64% | +92.13% | 19TCr | |
| Average | -0.15% | +3.28% | +28.76% | +55.69% | 39.44TCr | |
| Weighted average by Cap. | -0.51% | +3.52% | +37.86% | +71.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 863.35Cr 129.1Cr 115.08Cr 106.6Cr 97Cr 181.88Cr 12TCr 184.87Cr 1.28TCr 502.8Cr 6.4TCr 484.38Cr 474.24Cr 20TCr | 935.65Cr 139.91Cr 124.72Cr 115.53Cr 105.05Cr 197.12Cr 13TCr 200.36Cr 1.39TCr 544.91Cr 6.93TCr 524.94Cr 513.96Cr 22TCr |
| Net income | 133.73Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.9TCr 29Cr 198.05Cr 78Cr 990.89Cr 75Cr 73Cr 3.17TCr | 158.04Cr 24Cr 21Cr 20Cr 18Cr 33Cr 2.24TCr 34Cr 234.06Cr 92Cr 1.17TCr 89Cr 87Cr 3.74TCr |
| Net Debt | -154.39Cr -23Cr -21Cr -19Cr -17Cr -33Cr -2.19TCr -33Cr -228.65Cr -90Cr -1.14TCr -87Cr -85Cr -3.66TCr | -571.22Cr -85Cr -76Cr -71Cr -64Cr -120.34Cr -8.1TCr -122.32Cr -845.99Cr -332.67Cr -4.23TCr -320.48Cr -313.77Cr -14TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | CN¥14.39 | +2.49% | 1,56,61,400 |
| 16/26/16 | CN¥14.04 | -0.35% | 1,57,18,760 |
| 15/26/15 | CN¥14.09 | -1.33% | 1,54,05,764 |
| 14/26/14 | CN¥14.28 | +2.22% | 1,54,73,462 |
| 13/26/13 | CN¥13.97 | -1.76% | 1,24,02,956 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
